$RPD
Rapid7, Inc.

2023 Q2 Form 10-Q Financial Statement

#000156032723000028 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $190.4M $183.2M
YoY Change 13.72% 16.39%
Cost Of Revenue $58.16M $56.00M
YoY Change 7.17% 9.18%
Gross Profit $132.3M $127.2M
YoY Change 16.86% 19.87%
Gross Profit Margin 69.46% 69.43%
Selling, General & Admin $105.9M $104.8M
YoY Change 7.08% 8.41%
% of Gross Profit 80.09% 82.4%
Research & Development $50.76M $46.35M
YoY Change 3.79% -6.96%
% of Gross Profit 38.38% 36.44%
Depreciation & Amortization $11.83M $11.05M
YoY Change 269.66% 8.66%
% of Gross Profit 8.94% 8.69%
Operating Expenses $156.7M $151.1M
YoY Change 5.99% 3.19%
Operating Profit -$24.43M -$23.97M
YoY Change -29.5% -40.65%
Interest Expense -$14.25M $2.717M
YoY Change -616.82% 0.89%
% of Operating Profit
Other Income/Expense, Net -$13.27M -$307.0K
YoY Change 452.14% -49.09%
Pretax Income -$65.91M -$25.32M
YoY Change 66.58% -41.87%
Income Tax $869.0K $594.0K
% Of Pretax Income
Net Earnings -$66.78M -$25.92M
YoY Change 68.62% -42.41%
Net Earnings / Revenue -35.07% -14.15%
Basic Earnings Per Share -$1.10 -$0.43
Diluted Earnings Per Share -$1.10 -$0.43
COMMON SHARES
Basic Shares Outstanding 60.35M shares 60.04M shares
Diluted Shares Outstanding 60.47M shares 59.89M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $293.5M $262.2M
YoY Change 22.44% 11.82%
Cash & Equivalents $185.9M $205.8M
Short-Term Investments $107.6M $56.48M
Other Short-Term Assets $95.12M $75.70M
YoY Change 45.03% 9.65%
Inventory
Prepaid Expenses
Receivables $136.3M $116.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $524.9M $454.6M
YoY Change 22.08% 10.65%
LONG-TERM ASSETS
Property, Plant & Equipment $103.9M $56.64M
YoY Change 105.65% 13.72%
Goodwill $536.3M $538.0M
YoY Change 4.01% 4.41%
Intangibles $104.7M $111.4M
YoY Change -1.03% 2.94%
Long-Term Investments $2.437M $7.343M
YoY Change -82.99% -74.05%
Other Assets $83.35M $83.97M
YoY Change -1.16% 16.43%
Total Long-Term Assets $830.7M $874.8M
YoY Change -2.9% 1.37%
TOTAL ASSETS
Total Short-Term Assets $524.9M $454.6M
Total Long-Term Assets $830.7M $874.8M
Total Assets $1.356B $1.329B
YoY Change 5.45% 4.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.989M $8.475M
YoY Change 31.57% -30.32%
Accrued Expenses $81.57M $57.55M
YoY Change 22.95% 1.85%
Deferred Revenue $429.3M $414.0M
YoY Change 8.63% 9.42%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $520.5M $493.7M
YoY Change 7.6% 7.41%
LONG-TERM LIABILITIES
Long-Term Debt $817.9M $816.9M
YoY Change 0.48% 0.48%
Other Long-Term Liabilities $128.4M $13.36M
YoY Change 849.95% 0.84%
Total Long-Term Liabilities $946.2M $13.36M
YoY Change 6902.89% 0.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $520.5M $493.7M
Total Long-Term Liabilities $946.2M $13.36M
Total Liabilities $1.467B $1.440B
YoY Change 2.3% 2.07%
SHAREHOLDERS EQUITY
Retained Earnings -$953.4M -$886.7M
YoY Change 16.18% 13.52%
Common Stock $609.0K $603.0K
YoY Change 3.92% 3.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$111.0M -$110.2M
YoY Change
Total Liabilities & Shareholders Equity $1.356B $1.329B
YoY Change 5.45% 4.36%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$66.78M -$25.92M
YoY Change 68.62% -42.41%
Depreciation, Depletion And Amortization $11.83M $11.05M
YoY Change 269.66% 8.66%
Cash From Operating Activities $31.31M $5.842M
YoY Change 320.26% -43.84%
INVESTING ACTIVITIES
Capital Expenditures $5.724M $2.285M
YoY Change -165.74% -25.16%
Acquisitions $34.03M
YoY Change
Other Investing Activities -$46.28M -$3.116M
YoY Change -253.41%
Cash From Investing Activities -$52.01M -$10.18M
YoY Change -342.33% -71.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.177M $2.838M
YoY Change -166.05% -11.53%
NET CHANGE
Cash From Operating Activities 31.31M $5.842M
Cash From Investing Activities -52.01M -$10.18M
Cash From Financing Activities 1.177M $2.838M
Net Change In Cash -19.52M -$1.530M
YoY Change -171.97% -93.38%
FREE CASH FLOW
Cash From Operating Activities $31.31M $5.842M
Capital Expenditures $5.724M $2.285M
Free Cash Flow $25.58M $3.557M
YoY Change 58.34% -51.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001560327
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-37496
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
RAPID7, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2423994
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
120 Causeway Street
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Boston,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02114
CY2023Q1 dei City Area Code
CityAreaCode
617
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
247-1717
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
RPD
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60352051 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
205757000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
80306000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
207287000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
56483000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
84162000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2320000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2299000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
116683000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
152045000 usd
CY2023Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
36171000 usd
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
34906000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39527000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31907000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
454621000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
510307000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
7343000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
9756000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56638000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57891000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
77420000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
79342000 usd
CY2023Q1 us-gaap Deferred Costs
DeferredCosts
69144000 usd
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
68169000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
538037000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
515631000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
111432000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
101269000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
14824000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
16626000 usd
CY2023Q1 us-gaap Assets
Assets
1329459000 usd
CY2022Q4 us-gaap Assets
Assets
1358991000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8475000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10255000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57545000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12853000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12444000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
413992000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
426599000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
809000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1663000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
493674000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
531267000 usd
CY2023Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
816894000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
815948000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
84114000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
85946000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
31585000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
31040000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13364000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14864000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1439631000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1479065000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60891488 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60206277 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60321909 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59719469 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
603000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
597000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
569579 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
486808 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
4765000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
4764000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
780850000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
746249000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-200000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1411000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-886660000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-860745000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-110172000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-120074000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1329459000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1358991000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
183174000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157384000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
55999000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
51289000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
127175000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
106095000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46346000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49812000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
80587000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
75146000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24207000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21516000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
151140000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
146474000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23965000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-40379000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1668000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
112000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2717000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
2693000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-307000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-603000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25321000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43563000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
594000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1436000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25915000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44999000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59888119 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59888119 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57724821 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57724821 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25915000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44999000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
192000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-898000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-641000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-316000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
833000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-582000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
378000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-658000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1211000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1240000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24704000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46239000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-120074000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29518000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6174000 usd
CY2023Q1 rp Adjustments To Additional Paid In Capital Vesting Of Restricted Stock Units
AdjustmentsToAdditionalPaidInCapitalVestingOfRestrictedStockUnits
0 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1267000 usd
CY2023Q1 rp Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
181000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1211000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25915000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-110172000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-125995000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32475000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5710000 usd
CY2022Q1 rp Adjustments To Additional Paid In Capital Vesting Of Restricted Stock Units
AdjustmentsToAdditionalPaidInCapitalVestingOfRestrictedStockUnits
0 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3461000 usd
CY2022Q1 rp Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
959000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1240000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44999000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-136551000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25915000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44999000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11050000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10169000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
994000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
979000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
29373000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
28922000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-995000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-526000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35805000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-36327000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
2240000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
2939000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5567000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6556000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2744000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8673000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-23951000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-24048000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-12062000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3830000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
104000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-481000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5842000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10403000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
34033000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2285000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3053000 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4776000 usd
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3522000 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4883000 usd
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
32136000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
35800000 usd
CY2022Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2800000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10177000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35911000 usd
CY2023Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
2250000 usd
CY2022Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1267000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3461000 usd
CY2023Q1 rp Proceeds From Issuance Of Employee Stock Purchase Plan
ProceedsFromIssuanceOfEmployeeStockPurchasePlan
6174000 usd
CY2022Q1 rp Proceeds From Issuance Of Employee Stock Purchase Plan
ProceedsFromIssuanceOfEmployeeStockPurchasePlan
5710000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
181000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
959000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2838000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3208000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-33000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-800000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1530000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23100000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
207804000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165017000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206274000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141917000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
750000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
750000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
166000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
205757000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141365000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
517000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
552000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206274000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141917000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. </span></div>The management estimates include, but are not limited to the determination of standalone selling prices in revenue transactions with multiple performance obligations, the estimated period of benefit for deferred contract acquisition costs, the useful lives and recoverability of long-lived assets, the valuation for credit losses, the valuation of stock-based compensation, the fair value of assets acquired and liabilities assumed in business combinations, the incremental borrowing rate for operating leases and the valuation for deferred tax assets. We base our estimates on historical experience and on various other assumptions that we believe are reasonable. Actual results could differ from those estimates.
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
183174000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157384000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
163400000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
137300000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1100000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1200000 usd
CY2023Q1 rp Contract Assets
ContractAssets
0 usd
CY2022Q4 rp Contract Assets
ContractAssets
0 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
497111000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
204126000 usd
CY2023Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingunit
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
64290000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
466000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
63826000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
94760000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
846000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
93918000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
105140000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
102571000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
48502000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44680000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56638000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57891000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
3800000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
3300000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
538000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
515600000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
515631000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
538037000 usd
CY2023Q1 rp Acquired Finite Lived Intangible Assets Gross
AcquiredFiniteLivedIntangibleAssetsGross
149774000 usd
CY2023Q1 rp Acquired Finite Lived Intangible Assets Accumulated Amortization
AcquiredFiniteLivedIntangibleAssetsAccumulatedAmortization
70886000 usd
CY2023Q1 rp Acquired Finite Lived Intangible Assets Net
AcquiredFiniteLivedIntangibleAssetsNet
78888000 usd
CY2022Q4 rp Acquired Finite Lived Intangible Assets Gross
AcquiredFiniteLivedIntangibleAssetsGross
137174000 usd
CY2022Q4 rp Acquired Finite Lived Intangible Assets Accumulated Amortization
AcquiredFiniteLivedIntangibleAssetsAccumulatedAmortization
65665000 usd
CY2022Q4 rp Acquired Finite Lived Intangible Assets Net
AcquiredFiniteLivedIntangibleAssetsNet
71509000 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
197552000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
86120000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
111432000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
180176000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
78907000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
101269000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7200000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6900000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
21698000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
24963000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
21098000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14199000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
6781000 usd
CY2023Q1 rp Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
5119000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
93858000 usd
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
17600000 usd
CY2023Q1 rp Operating Lease Number Of Lease Renewal Options
OperatingLeaseNumberOfLeaseRenewalOptions
1 leaserenewaloption
CY2023Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023Q1 rp Lessee Operating Lease Termination Period
LesseeOperatingLeaseTerminationPeriod
P1Y
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
4381000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
5013000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
324000 usd
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
391000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
2289000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
2385000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
6994000 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
7789000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.062
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.062
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
6689000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
4659000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1151000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8864000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
13309000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
19067000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
18159000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
16782000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
15952000 usd
CY2023Q1 rp Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
34955000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
118224000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
21257000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
96967000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29373000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28922000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2023Q1 rp Share Based Compensation Arrangement By Share Based Payment Award Number Of Vesting Installments
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments
3 installment
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
932126 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.70
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
19837000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
16812 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.74
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
568000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
915314 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.73
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
30366000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
915314 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.73
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
30366000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25915000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44999000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59888119 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59888119 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57724821 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57724821 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14914794 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15122283 shares
CY2018Q4 us-gaap Loss Contingency Patents Allegedly Infringed Number
LossContingencyPatentsAllegedlyInfringedNumber
7 patent
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q1 us-gaap Revenues
Revenues
183174000 usd
CY2022Q1 us-gaap Revenues
Revenues
157384000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56638000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57891000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001560327-23-000028-index-headers.html Edgar Link pending
0001560327-23-000028-index.html Edgar Link pending
0001560327-23-000028.txt Edgar Link pending
0001560327-23-000028-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q1202310-qexx311.htm Edgar Link pending
q1202310-qexx312.htm Edgar Link pending
q1202310-qexx321.htm Edgar Link pending
q1202310-qexx322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rp-20230331.htm Edgar Link pending
rp-20230331.xsd Edgar Link pending
Show.js Edgar Link pending
rp-20230331_cal.xml Edgar Link unprocessable
rp-20230331_def.xml Edgar Link unprocessable
rp-20230331_lab.xml Edgar Link unprocessable
rp-20230331_pre.xml Edgar Link unprocessable
rp-20230331_htm.xml Edgar Link completed